Rebecca Wilkins, Divisional Vice President of R&D Neuromodulation at Abbott, discusses the evolving role of deep brain stimulation in Parkinson disease, including patient selection, newer DBS technologies, and integration with emerging therapies.
Rebecca Wilkins
Advertisement
Articles by Rebecca Wilkins
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Accepts sNDAs for Casimersen and Golodirsen, Chris Johnson Diagnosed with ALS, Phase 2 Trial of NEU-411 Expands
2
NeurologyLive® Friday 5 — July 3, 2026
3
FDA Clears PoNS Device for Stroke Rehabilitation, Expanding Neurostimulation Beyond MS Indication
4
Where Tolebrutinib Fits: Weighing the EU Approval, FDA Divergence, and the Road Ahead in nrSPMS
5